Psychedelics Weekly – AIMS vs. the DEA: An Update on the Fight to Reschedule Psilocybin

In this episode, David is joined by Director of Advocacy at the National Psychedelics Association, Kathryn L. Tucker, JD, who updates us on the 3 AIMS vs. the DEA cases, discussing what their outcome could mean for the future.

www.psychedelicstoday.com